Cargando…
An Improved Protocol for Establishment of AML Patient-Derived Xenograft Models
Patient-derived xenografts (PDXs) are the most valuable tool for preclinical drug testing because they retain the genetic diversity and phenotypic heterogeneity of the original tumor. Acute myeloid leukemia (AML) remains difficult to engraft in immunodeficient mice. This is particularly true for lon...
Autores principales: | Hassan, Nunki, Yang, Jonason, Wang, Jenny Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7757302/ https://www.ncbi.nlm.nih.gov/pubmed/33377050 http://dx.doi.org/10.1016/j.xpro.2020.100156 |
Ejemplares similares
-
Protocol to establish a stable MLL-AF9_AML mouse model
por: Lu, Jun, et al.
Publicado: (2022) -
Establishment and Use of Patient-Derived Xenograft Models for Drug Testing in Head and Neck Squamous Cell Carcinoma
por: Karamboulas, Christina, et al.
Publicado: (2020) -
A Patient-Derived Xenograft Model of Glioblastoma
por: Chokshi, Chirayu R., et al.
Publicado: (2020) -
Protocol for derivation of organoids and patient-derived orthotopic xenografts from glioma patient tumors
por: Oudin, Anaïs, et al.
Publicado: (2021) -
Protocol to generate a patient derived xenograft model of acquired resistance to immunotherapy in humanized mice
por: Martínez-Sabadell, Alex, et al.
Publicado: (2022)